Literature DB >> 27246083

Progression to COPD in smokers with normal spirometry/low DLCO using different methods to determine normal levels.

Ben-Gary Harvey1, Yael Strulovici-Barel2, Robert J Kaner3, Abraham Sanders4, Thomas L Vincent5, Jason G Mezey6, Ronald G Crystal7.   

Abstract

Mesh：

Year:  2016        PMID： 27246083     DOI： 10.1183/13993003.00435-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  3 in total

Review 1.  Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.

Authors:  Andrea Rossi; Bojana Butorac-Petanjek; Marco Chilosi; Borja G Cosío; Matjaz Flezar; Nikolaos Koulouris; José Marin; Neven Miculinic; Guido Polese; Miroslav Samaržija; Sabina Skrgat; Theodoros Vassilakopoulos; Andrea Vukić-Dugac; Spyridon Zakynthinos; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-08-29

2.  Bronchodilator responsiveness or reversibility in asthma and COPD - a need for clarity.

Authors:  Igor Barjaktarevic; Robert Kaner; Russell G Buhr; Christopher B Cooper
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-23

3.  β2-microglobulin as a biomarker of pulmonary fibrosis development in COPD patients.

Authors:  Zhenchao Wu; Mengdie Yan; Min Zhang; Nan Wu; Guoyuan Ma; Bingbing Wang; Youbo Fan; Xintong Du; Can Ding; Yi Liu
Journal:  Aging (Albany NY)       Date:  2020-12-21       Impact factor: 5.682
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.